International Quality ADRs: Best-in-Class Companies Outside the US
The best companies in the world are not all American. ASML, Novo Nordisk, and TSMC would be top holdings in any quality portfolio.
Stoquity AI Committee1Theme Overview
International stocks have underperformed US equities for 15+ years, creating a historic valuation gap. International markets trade at 13x forward earnings versus 22x for the US. Many world-class companies outside the US offer comparable quality at lower prices.
2Why Now?
Dollar strength appears to be peaking, which historically triggers international outperformance. European and Asian companies are improving corporate governance and increasing shareholder returns (buybacks, dividends). The valuation gap is at its widest in decades.
3Screening Methodology
Screen for US-listed ADRs of international companies scoring in the top quintile on quality, trading at valuation discounts to US sector peers.
Factors used: QualityProfitabilityValueRevenue GrowthCash Flow
4Top Picks (5 Stocks)
Thesis: Monopoly supplier of EUV lithography systems essential for advanced chip manufacturing. $40B+ backlog with 50%+ gross margins. Every leading chipmaker (TSMC, Samsung, Intel) is a customer.
Risks: China export restrictions limit addressable market; cyclical semiconductor capex; geopolitical tension affecting European companies.
Thesis: Global GLP-1 leader with Ozempic and Wegovy dominating diabetes and obesity markets. Revenue growing 30%+ driven by weight-loss drug demand. Manufacturing expansion underway to address supply constraints.
Risks: GLP-1 competition from Eli Lilly; manufacturing capacity bottlenecks; potential regulatory price controls outside US.
Thesis: Enterprise software leader with 80%+ of Fortune 500 as customers. Cloud transition driving recurring revenue above 80%. S/4HANA migration cycle extends through 2027+.
Risks: Cloud transition margin dilution; long migration cycles create execution risk; competition from Oracle and Workday.
Thesis: Leading e-commerce platform powering 10%+ of US e-commerce. Merchant solutions (payments, shipping, capital) driving revenue diversification. Enterprise upmarket push gaining traction.
Risks: E-commerce growth normalization; competition from Amazon; merchant churn in economic downturns.
Thesis: World's largest automaker by volume. Hybrid strategy proving prescient as EV growth slows. Trading at 9x earnings with record profitability. Balance sheet holds $50B+ net cash.
Risks: Yen appreciation compresses export profitability; EV transition uncertainty; governance reforms under pressure.
View compact comparison table
| Symbol | Name | Sector | Score | Market Cap |
|---|---|---|---|---|
| ASML | ASML Holding | Semiconductors | 92 | $350B |
| NVO | Novo Nordisk | Healthcare | 90 | $430B |
| SAP | SAP SE | Software | 86 | $290B |
| SHOP | Shopify (Canadian) | Technology | 84 | $120B |
| TM | Toyota Motor | Automotive | 80 | $260B |
5Theme Risks
International investing adds currency risk, geopolitical risk, and potentially different accounting standards. ADRs can trade at premiums/discounts to local shares. Many international markets have structural growth headwinds (demographics, regulation).
Non-US stocks trade at a 30%+ P/E discount to US equities despite similar quality metrics — the widest valuation gap in 20 years.
Screen stocks yourself
Use the same 24-factor scoring model that powers Stoquity portfolios.
Try the AI Screener →